First pertussis vaccine dose and prevention of infant mortality

Pediatrics

Volumn 135, Issue 6, 2015, Pages 990-999

  Tiwari, Tejpratap S P ^a   Baughman, Andrew L ^b   Clark, Thomas A ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PERTUSSIS VACCINE;

ALASKA NATIVE; AMERICAN INDIAN; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG USE; FATALITY; FEMALE; HISPANIC; HUMAN; INFANT; INFANT MORTALITY; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; PERTUSSIS; PNEUMONIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK ASSESSMENT; VACCINATION; MORTALITY; WHOOPING COUGH;

FEMALE; HUMANS; INFANT; INFANT MORTALITY; MALE; PERTUSSIS VACCINE; WHOOPING COUGH;

EID: 84930582069     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2014-2291     Document Type: Article

References (48)

1. Tanaka M, Vitek CR, Pascual FB, Bisgard KM, Tate JE, Murphy TV. Trends in pertussis among infants in the United States, 1980-1999. JAMA. 2003;290(22):2968-2975
2. Vitek CR, Pascual FB, Baughman AL, Murphy TV. Increase in deaths from pertussis among young infants in the United States in the 1990s. Pediatr Infect Dis J. 2003;22(7):628-634
3. Wortis N, Strebel PM, Wharton M, Bardenheier B, Hardy IR. Pertussis deaths: report of 23 cases in the United States, 1992 and 1993. Pediatrics. 1996;97(5):607-612
4. Centers for Disease Control and Prevention. Brief report: fatal case of pertussis in an infant - West Virginia, 2004. MMWR Morb Mortal Wkly Rep. 2005;54(03):71-72
5. Shaikh R, Guris D, Strebel PM, Wharton M. Underreporting of pertussis deaths in the United States: need for improved surveillance. Pediatrics. 1998;101(2):323
6. Roush SW, Murphy TV; Vaccine-Preventable Disease Table Working Group. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. JAMA. 2007;298(18):2155-2163
7. Cortese MM, Baughman AL, Zhang R, Srivastava PU, Wallace GS. Pertussis hospitalizations among infants in the United States, 1993 to 2004. Pediatrics. 2008;121(3):484-492
8. Clark TA. Changing pertussis epidemiology: everything old is new again. J Infect Dis. 2014;209(7):978-981
9. Centers for Disease Control and Prevention. Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1997;46(RR-7):1-25
10. Centers for Disease Control and Prevention. Food and Drug Administration approval of an acellular pertussis vaccine for the initial four doses of the diphtheria, tetanus, and pertussis vaccination series. MMWR Morb Mortal Wkly Rep. 1996;45(31):676-677
11. Jefferson T, Rudin M, DiPietrantonj C. Systematic review of the effects of pertussis vaccines in children. Vaccine. 2003;21(17-18):2003-2014
12. Kroger AT, Atkinson WL, Marcuse EK, Pickering LK; Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006;55(RR-15):1-48
13. Centers for Disease Control and Prevention. National and state vaccination coverage among children aged 19-35 months - United States, 2010. MMWR Morb Mortal Wkly Rep. 2011;60(34):1157-1163
14. Bisgard KM, Rhodes P, Connelly BL, et al; Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001. Pediatrics. 2005;116(2). Available at: http://pediatrics.aappublications.org/content/116/2/e285.full.pdf. Accessed March 31, 2015
15. Greco D, Salmaso S, Mastrantonio P, et al Progetto Pertosse Working Group. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. N Engl J Med. 1996;334(6):341-348
16. Briand V, Bonmarin I, Lévy-Bruhl D. Study of the risk factors for severe childhood pertussis based on hospital surveillance data. Vaccine. 2007;25(41):7224-7232
17. Juretzko P, von Kries R, Hermann M, Wirsing von König CH, Weil J, Giani G. Effectiveness of acellular pertussis vaccine assessed by hospital-based active surveillance in Germany. Clin Infect Dis. 2002;35(2):162-167
18. Centers for Disease Control and Prevention. National Notifiable Diseases Surveillance System (NNDSS). Available at: http://wwwn.cdc.gov/nndss/. Accessed February 24, 2015
19. Council of State and Territorial Epidemiologists. CSTE Annual Meeting, Saratoga Springs, NY: Public Health Surveillance, Control, and Prevention of Pertussis. Position Statement No 9. 1997. Available at: http://c.ymcdn.com/sites/www.cste.org/resource/resmgr/PS/1997-Id-9.pdf. Accessed on March 31, 2015
20. Centers for Disease Control and Prevention. Bridged-race population estimates 1990-2009. Available at: http://wonder.cdc.gov/bridged-race-v2009.html. Accessed March 31, 2015
21. Tiwari T, Murphy TV, Moran J; National Immunization Program, Centers for Disease Control and Prevention. Recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis: 2005 CDC guidelines. MMWR Recomm Rep. 2005;54(RR-14):1-16
22. Centers for Disease Control and Prevention. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices and the American Academy of Family Physicians. MMWR. 2002;51(RR-2):4-5
23. SAS Institute. SAS/STAT Users Guide. Version 9.3. Cary, NC: SAS Institute; 2012
24. Ausiello CM, Urbani F, La Sala A, Lande R, Piscitelli A, Cassone A. Acellular vaccines induce cell-mediated immunity to Bordetella pertussis antigens in infants undergoing primary vaccination against pertussis. Dev Biol Stand. 1997;89:315-320
25. Carbonetti NH. Immunomodulation in the pathogenesis of Bordetella pertussis infection and disease. Curr Opin Pharmacol. 2007;7(3):272-278
26. Peppoloni S, Nencioni L, Di Tommaso A, et al. Lymphokine secretion and cytotoxic activity of human CD4+ T-cell clones against Bordetella pertussis. Infect Immun. 1991;59(10):3768-3773
27. Warfel JM, Beren J, Kelly VK, Lee G, Merkel TJ. Nonhuman primate model of pertussis. Infect Immun. 2012;80(4):1530-1536
28. Warfel JM, Merkel TJ. Bordetella pertussis infection induces a mucosal IL-17 response and long-lived Th17 and Th1 immune memory cells in nonhuman primates. Mucosal Immunol. 2013;6(4):787-796
29. Warfel JM, Merkel TJ. Reply to Domenech de Cellès et al.: infection and transmission of pertussis in the baboon model. Proc Natl Acad Sci USA. 2014;111(7):E718
30. Mahon BP, Ryan MS, Griffin F, Mills KH. Interleukin-12 is produced by macrophages in response to live or killed Bordetella pertussis and enhances the efficacy of an acellular pertussis vaccine by promoting induction of Th1 cells. Infect Immun. 1996;64(12):5295-5301
31. Mills KHG. Immunity to Bordetella pertussis. Microbes Infect. 2001;3(8):655-677
32. Higgs R, Higgins SC, Ross PJ, Mills KH. Immunity to the respiratory pathogen Bordetella pertussis. Mucosal Immunol. 2012;5(5):485-500
33. Centers for Disease Control and Prevention. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women - Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep. 2013;62(7):131-135
34. Warfel JM, Papin JF, Wolf RF, Zimmerman LI, Merkel TJ. Maternal and neonatal vaccination protects newborn baboons from pertussis infection. J Infect Dis. 2014;210(4):604-610
35. Amirthalingam G, Andrews N, Campbell H, et al. Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet. 2014;384(9953):1521-1528
36. Dabrera G, Amirthalingam G, Andrews N, et al. A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales, 2012-2013. Clin Infect Dis. 2015;60(3):333-337
37. Centers for Disease Control and Prevention. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months - Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. 2011;60(41):1424-1426
38. Warfel JM, Zimmerman LI, Merkel TJ. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc Natl Acad Sci USA. 2014;111(2):787-792
39. Healy CM, Rench MA, Baker CJ. Implementation of cocooning against pertussis in a high-risk population. Clin Infect Dis. 2011;52(2):157-162
40. Halasa NB, O'Shea A, Shi JR, LaFleur BJ, Edwards KM. Poor immune responses to a birth dose of diphtheria, tetanus, and acellular pertussis vaccine. J Pediatr. 2008;153(3):327-332
41. Knuf M, Schmitt HJ, Wolter J, et al. Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infants. J Pediatr. 2008;152(5):655-660, e1
42. Wood N, McIntyre P, Marshall H, Roberton D. Acellular pertussis vaccine at birth and one month induces antibody responses by two months of age. Pediatr Infect Dis J. 2010;29(3):209-215
43. Jahnmatz M, Amu S, Ljungman M, et al. B-cell responses after intranasal vaccination with the novel attenuated Bordetella pertussis vaccine strain BPZE1 in a randomized phase I clinical trial. Vaccine. 2014;32(27):3350-3356
44. Feunou PF, Kammoun H, Debrie A-S, Locht C. Heterologous prime-boost immunization with live attenuated B. pertussis BPZE1 followed by acellular pertussis vaccine in mice. Vaccine. 2014;32(34):4281-4288
45. Halasa NB, Barr FE, Johnson JE, Edwards KM. Fatal pulmonary hypertension associated with pertussis in infants: does extracorporeal membrane oxygenation have a role? Pediatrics. 2003;112(6 pt 1):1274-1278
46. Goulin GD, Kaya KM, Bradley JS. Severe pulmonary hypertension associated with shock and death in infants infected with Bordetella pertussis. Crit Care Med. 1993;21(11):1791-1794
47. Sreenan CD, Osiovich H. Neonatal pertussis requiring extracorporeal membrane oxygenation. Pediatr Surg Int. 2001;17(2-3):201-203
48. Pierce C, Klein N, Peters M. Is leukocytosis a predictor of mortality in severe pertussis infection? Intensive Care Med. 2000;26(10):1512-1514